Calliditas Therapeutics AB Basic And Diluted Earnings Loss Per Share
Calliditas Therapeutics AB reported Basic And Diluted Earnings Loss Per Share of -$9.66 per share for the 12-month period ending 2020-12-31, per its 20-F/A filed 2022-01-14.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:BasicAndDilutedEarningsLossPerShare · last filed 2022-01-14
| Period end | Basic And Diluted Earnings Loss Per Share 12 month |
|---|---|
| 2020-12-31 | -$9.66 20-F/A · filed 2022-01-14 |
| 2019-12-31 | -$0.88 20-F/A · filed 2022-01-14 |
| 2018-12-31 | -$5.09 20-F/A · filed 2022-01-14 |